|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Frequen- cy of cytochrome P450 CYP2C9 variants in a Turkish pop- ulation and functional relevance for phenytoin显示文摘 | Aynacioglu AS Brockmoller J Bauer S | 1999 | Brit J Clin Pharmaco1999，48，3： | 1 |
| 2 | Frequen- cy of cytoehrome P450 CYP2C9 variants in a Turkish popu- lation and functional relevance for phenytoin显示文摘 | Aynacioglu AS Brockmisller J Bauer S | 1999 | Br J Clin Pharmacol1999，48，3： | 1 |
| 3 | Human arylamine N-acetyl- transferase 2 polymorphism and susceptibility to allergic contact dermatitis显示文摘 | Nacak M Erbagci Z Aynacioglu AS | 2006 | Int J Dermato12006，45，3： | 1 |
| 4 | The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphismsfor phenytoin plasma levels显示文摘 | Kerb R Aynacioglu AS Brockmolter J | 2001 | Pharmacogenomies2001，1，： | 1 |
| 5 | Paraoxonase 1 mutations in a Turkish population显示文摘 | Aynacioglu AS Cascorbi I Mrozikiewicz PM | 1999 | Toxicol Appl Pharmacol1999，157，3： | 1 |
| 6 | Neonatal jaundice and bilirubin UDP- glucuronosyl transferase 1A1 gene polymorphism in turkish patients显示文摘 | Babaoglu MO Yigit S Aynacioglu AS | 2006 | Boa Clin Pharmacol Toxicol2006，98，4： | 1 |
| 7 | The predictive value of MDR1,CYP2C9,and CYP2C19 polymorphisms for phenytoin plasma levels显示文摘 | Kerb R Aynacioglu AS Brockmoller J | 2001 | Pharmacogenomics2001，1，： | 1 |
| 8 | Paraoxonase 1 mutations in a Turkish population显示文摘 | Aynacioglu AS Cascorbi I Mrozikiewicz PM | 1999 | Toxicology and Applied Pharmacology1999，157，： | 1 |
| 9 | Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin显示文摘 | Aynacioglu AS Brockmoller J Bauer S | 1999 | Br J Clin Pharmacol1999，48，3： | 1 |
| 10 | Cytochrome P4502C9 genotype in Southeast Anatolia and possible relation with some serum tumour markers and cytokines显示文摘 | Yilmaz N Erbagci AB Aynacioglu AS | 2001 | Acta Biochim Pol2001，48，3： | 1 |
| 11 | The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels 显示文摘 | Kerb R Aynacioglu AS Brockmoller J | 2001 | Pharmacogenomics J2001，1，： | 1 |
| 12 | Population frequency, mutation linkage and analytical methodology for he Argl6Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks显示文摘 | Aynacioglu AS Cascorbi I Gang6r K | 1999 | Br J Clin Pharmacol1999，48，5： | 1 |
| 13 | Frequency of the 17-bp variable number of tandem repeat polymorphism in Turkish schizophrenic patients显示文摘 | Herken H Erdal ME Aynacioglu AS | | 0，，： | 1 |
| 14 | Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional rele- vance for phenytoin 显示文摘 | Aynacioglu AS BrockmiJller J Bauer S | 1999 | Br J Clin Pharmacol1999，48，3： | 1 |
| 15 | Association between the N-acetylation genetic polymorphism and bronchial asthma 显示文摘 | Nacak M Aynacioglu AS Filiz A | 2002 | Br J Clin Pharmacol2002，54，6： | 1 |
| 16 | Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin显示文摘 | Brockmoller J Bauer S | 1999 | Br J Clin Pharmacol1999，48，3： | 1 |
| 17 | The predictive value of MDR1,CYP2C9,and CYP2C19 polymorphisms for phenytoin plasma levels显示文摘 | Kerb R Aynacioglu AS Brockmoller J | 2001 | Harmacogenomics2001，1，3： | 1 |
| 18 | Paraoxonase 1 mutations in a Turkish population 显示文摘 | Aynacioglu AS Cascorbi I Mrozikiewicz PM | 1999 | Toxicol Appl Pharmacol1999，157，： | 1 |
| 19 | Human arylamine N acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis显示文摘 | Nacak M Erbagci Z Aynacioglu AS | 2006 | Int J Dermatol2006，15，3： | 1 |
| 20 | The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels显示文摘 | Kerb R Aynacioglu AS Brockmtaller J | 2001 | Pharmacogenomics J2001，1，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员